SOPHiA GENETICS SA

General Information
Business:

SOPHiA GENETICS was founded to generate clinically actionable insights from data to improve patient outcomes. Our mission is to provide equal access to knowledge and capabilities by democratizing data-driven medicine.

We observed that across the healthcare ecosystem, a vast amount of digital healthcare data was being generated, fueled by technologies such as NGS (next-generation sequencing), and which held promise to accelerate the understanding of biology and disease. However, this data has been generated primarily using non-standardized methods and by clinicians and researchers across many healthcare institutions. As a result, the data remained siloed and complex and was not fully leveraged for the benefit of patients.

We built a cloud-based software-as-a-service (“SaaS”) platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. Our platform standardizes, computes and analyzes digital health data and is used across decentralized locations to break down data silos. This enables healthcare institutions to share knowledge and experiences and to build a collective intelligence. We envision a future in which all clinical diagnostic test data is channeled through a decentralized analytics platform that will provide insights powered by large real-world data sets and AI.

(Note: Sophia Genetics priced its IPO on July 22, 2021, at $18 – the mid-point of its $17-to-$19 range – on 13 million shares, the same number of shares in the prospectus, to raise $234 million.)

(Note: On its first day of trading on July 23, 2021, Sophia Genetics’ stock opened at $18.45, hit an intraday high of $18.74, and closed at $16.76.)

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 462
Founded: 2011
Contact Information
Address Rue du Centre 172 CH-1025 Saint-Sulpice Switzerland
Phone Number + 41 21 694 10 60
Web Address http://www.sophiagenetics.com
View Prospectus: SOPHiA GENETICS SA
Financial Information
Market Cap $886.1mil
Revenues $29.9 mil (last 12 months)
Net Income $-41.5 mil (last 12 months)
IPO Profile
Symbol SOPH
Exchange NASDAQ
Shares (millions): 13.0
Price range $18.00 - $18.00
Est. $ Volume $234.0 mil
Manager / Joint Managers J.P. Morgan/ Morgan Stanley/ Cowen/ Credit Suisse
CO-Managers -
Expected To Trade: 7/23/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change